文献速递胰腺与胆道疾病消化内镜消化道肿瘤与早癌

困难胆管插管时晚期插管技术对比早期EUS-BD:倾向性评分匹配分析

Advanced cannulation techniques vs early EUS-BD in case of difficult biliary cannulation in patients with DMBO: an international propensity score-matched analysis.
PubMed 文献 · Am J Gastroenterol · 2026-08-10

这项回顾性多中心研究纳入远端恶性胆道梗阻且胆总管直径>12 mm的患者,比较困难插管后采用早期超声内镜引导下胆道引流(eEUS-BD)与晚期插管技术(aERCP)的安全性和有效性。匹配后分析显示,eEUS-BD的不良事件发生率低于aERCP(9.3% vs 18.2%,p<0.01),技术成功率更高(95.9% vs 82.0%,p<0.01),临床成功率相当。

要点

  • eEUS-BD不良事件发生率9.3%,低于aERCP的18.2%
  • eEUS-BD技术成功率95.9%,高于aERCP的82.0%
  • 两组临床成功率相当(96.4% vs 94.5%,p=0.89)

核心结论

  • 在远端恶性胆道梗阻且胆总管扩张的患者中,eEUS-BD较aERCP不良事件更少、技术成功率更高,支持其作为困难胆管插管时更安全有效的选择。

研究设计与样本

  • 回顾性多中心研究,纳入美国、加拿大、欧洲29个中心截至2024年治疗的远端恶性胆道梗阻且胆总管直径>12 mm患者。
  • 标准插管失败后接受eEUS-BD或aERCP的困难插管病例被分析,采用1:2倾向性评分匹配生成队列,并以回归建模和逆概率治疗加权(IPTW)作为敏感性分析。

主要发现

  • 标准插管在2066/10738例(19.2%)ERCP中失败。
  • aERCP和eEUS-BD分别尝试1733例和333例;匹配后eEUS-BD组313例、aERCP组626例被分析。
  • 不良事件发生率aERCP为18.2%、eEUS-BD为9.3%(p<0.01),aERCP后最常见不良事件为术后胰腺炎(55例,12.0%)。
  • 技术成功率aERCP显著更低(82.0% vs 95.9%,p<0.01),临床成功率相当(94.5% vs 96.4%,p=0.89)。
  • 回归和IPTW分析在全队列中证实上述发现的稳健性。

关键数值与推荐

  • 纳入标准:远端恶性胆道梗阻且胆总管直径>12 mm。
  • 主要结局为不良事件发生率;次要结局包括胆道引流失败和临床成功。

临床怎么用

  • 对于远端恶性胆道梗阻伴胆总管扩张且标准插管失败的困难插管患者,可考虑早期EUS-BD以降低不良事件风险并提高技术成功率。

局限性

  • 本研究为回顾性设计,可能存在选择偏倚等固有局限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Biliary drainage(BD)in distal malignant biliary obstruction(DMBO)is often hampered by difficult biliary cannulation(DBC)during endoscopic retrograde cholangiopancreatography(ERCP). Advanced cannulation techniques(aERCP)may overcome DBC but still fail in up to 15% of cases, increasing the risk of adverse events(AEs). Early endoscopic ultrasound-guided BD(eEUS-BD)is a potential alternative. The aim of this study is to directly compare safety and efficacy of EUS-BD and aERCP. METHODS: This is a retrospective, multicentric study(29 centres in United States, Canada, Europe), including patients with DMBO and common bile duct(CBD)diameter >12 mm, treated up to 2024. DBC cases managed with either eEUS-BD or aERCP were analysed. A 1:2 propensity score-matched cohort was generated to ensure comparability, with regression modeling and inverse probability of treatment weighting(IPTW)performed as sensitivity analyses. AEs rate was the primary outcome; secondary outcomes included BD failure and clinical success. RESULTS: Standard cannulation failed in 2066/10,738(19.2%)ERCPs. aERCP and eEUS-BD were attempted in 1733 and 333 cases, respectively. After matching, 313 patients per EUS-BD group and 626 patients per aERCP group were analyzed. AEs occurred in 18.2% of aERCPs and 9.3% of eEUS-BD(p<0.01), with post-procedural pancreatitis the most frequent AE after aERCP(55 cases, 12.0%). Both regression and IPTW confirmed the robustness of these findings on the entire cohort. Technical success was significantly lower with aERCP(82.0% vs. 95.9%, p<0.01), clinical success was comparable(94.5% vs. 96.4%, p=0.89). CONCLUSIONS: In patients with DMBO and dilated CBD, eEUS-BD is associated with fewer AEs and higher technical success than aERCP, supporting its role as a safer, more effective option in DBC.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Spadaccini M, Albouys J, Binda C, et al. Advanced cannulation techniques vs early EUS-BD in case of difficult biliary cannulation in patients with DMBO: an international propensity score-matched analysis. Am J Gastroenterol. 2026. PMID: 42572882. doi:10.14309/ajg.0000000000004182

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。